Overview

Update
IPO / Stock
Went Public on May 10, 2013 / NASDAQ:OVAS
Total Equity Funding
$82M in 4 Rounds from 5 Investors
Headquarters:
Boston, MA
Description:
OvaScience is a life sciences company focused on the discovery, development and commercialization of treatments for infertility.
Founders:
, ,
Categories:
Health Care, Biotechnology, Life Science
Website:
http://ovascience.com
Social:

Company Details

Update

The company is applying innovative science to improve the quality of eggs (oocytes) and increase the success of in vitro fertilization (IVF). OvaScience's proprietary technology, exclusively licensed from Harvard Medical School and Massachusetts General Hospital, enables the use of a women's own cellular energy to improve egg quality. OvaScience was co-founded by Richard Aldrich, Michelle Dipp, M.D., Ph.D., and Christoph Westphal M.D., Ph.D., of Longwood Founders Fund, along with fertility expert and Harvard Medical School Professor Jonathan Tilly, Ph.D. of Massachusetts General Hospital, and aging expert and Harvard Medical School Professor David Sinclair, Ph.D. The company is backed by leading life science investors Longwood Founders Fund and Bessemer Venture Partners. The company has assembled a world-class team of leading reproductive endocrinologists, embryologists, scientists and advisers to bring this technology to patients.

Funding Rounds (5) - $135.8M

Update
DateAmount / RoundValuationLead InvestorInvestors
Jun, 2016$53.8M / Post Ipo Equity0
Mar, 2013$35M / Series D0
Aug, 2012$4M / Series C0
Apr, 2012$37M / Series B5
Oct, 2011$6M / Series A0

Current Team (3)

Update

Board Members and Advisors (3)

Update

Offices/Locations (1)

Update
  • Office

    The Prudential Tower

    800 Boylston Street, Suite 1555

    Boston, MA 02199

    USA

Past Team (3)

Update

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos